AF_AFQ99650F1

Computed structure model of Oncostatin-M-specific receptor subunit beta

External Resource: Annotation

Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Oncostatin-M-specific receptor subunit beta	molecular transducer activity transmembrane signaling receptor activity signaling receptor activity cytokine receptor activity immune receptor activity protein binding binding growth factor binding ciliary neurotrophic factor receptor binding signaling receptor binding cytokine receptor binding cytokine binding	regulation of biological process cell population proliferation regulation of cellular process positive regulation of cell population proliferation regulation of cell population proliferation biological regulation positive regulation of biological process cellular process positive regulation of cellular process cellular response to stimulus cell surface receptor signaling pathway response to stimulus signaling response to cytokine regulation of biological process cell population proliferation regulation of cellular process positive regulation of cell population proliferation regulation of cell population proliferation biological regulation positive regulation of biological process cellular process positive regulation of cellular process cellular response to stimulus cell surface receptor signaling pathway response to stimulus signaling response to cytokine cytokine-mediated signaling pathway cell communication response to peptide response to chemical cellular response to cytokine stimulus signal transduction regulation of defense response regulation of response to external stimulus defense response response to external stimulus regulation of inflammatory response positive regulation of acute inflammatory response positive regulation of response to stimulus positive regulation of response to external stimulus positive regulation of inflammatory response regulation of response to stimulus response to stress regulation of response to stress positive regulation of defense response regulation of acute inflammatory response inflammatory response acute inflammatory response oncostatin-M-mediated signaling pathway	protein-containing complex receptor complex cell periphery cellular anatomical structure cell surface membrane plasma membrane external side of plasma membrane side of membrane oncostatin-M receptor complex plasma membrane protein complex plasma membrane signaling receptor complex membrane protein complex apical part of cell protein-containing complex receptor complex cell periphery cellular anatomical structure cell surface membrane plasma membrane external side of plasma membrane side of membrane oncostatin-M receptor complex plasma membrane protein complex plasma membrane signaling receptor complex membrane protein complex apical part of cell plasma membrane region apical plasma membrane

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR048497	Leukemia inhibitory factor receptor-like, Ig-like domain	Domain
A	IPR003961	Fibronectin type III	Domain
A	IPR052672	Type I Cytokine Receptor Family, Type 2 Subfamily	Family
A	IPR013783	Immunoglobulin-like fold	Homologous Superfamily
A	IPR040817	Leukemia inhibitory factor receptor, D2 domain	Domain
A	IPR003529	Long hematopoietin receptor, Gp130 family 2, conserved site	Conserved Site
A	IPR036116	Fibronectin type III superfamily	Homologous Superfamily

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: Q99650	non-small cell lung carcinoma amyloidosis, primary localized cutaneous, 1 malignant mesothelioma ulcerative colitis amyloidosis lung cancer malignant glioma MALT lymphoma acquired metabolic disease pancreatic ductal adenocarcinoma pilocytic astrocytoma Crohn disease psoriasis gastric carcinoma subependymal giant cell astrocytoma non-small cell lung carcinoma amyloidosis, primary localized cutaneous, 1 malignant mesothelioma ulcerative colitis amyloidosis lung cancer malignant glioma MALT lymphoma acquired metabolic disease pancreatic ductal adenocarcinoma pilocytic astrocytoma Crohn disease psoriasis gastric carcinoma subependymal giant cell astrocytoma head and neck cancer interstitial cystitis limb-girdle muscular dystrophy lung carcinoma medulloblastoma osteosarcoma adenoma pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia atypical teratoid rhabdoid tumor pituitary cancer diabetes mellitus sarcoidosis Gaucher disease IgA glomerulonephritis juvenile dermatomyositis lung adenocarcinoma malignant ependymoma malignant pancreatic neoplasm myopathy ovarian cancer periodic fever syndrome congestive heart failure primary cutaneous amyloidosis familial primary localized cutaneous amyloidosis spina bifida glioblastoma vascular disease inflammatory bowel disease large cell medulloblastoma

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.